Illumina's most recent trend suggests a bearish bias. One trading opportunity on Illumina is a Bear Call Spread using a strike $170.00 short call and a strike $180.00 long call offers a potential 9.89% return on risk over the next 8 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $170.00 by expiration. The full premium credit of $0.90 would be kept by the premium seller. The risk of $9.10 would be incurred if the stock rose above the $180.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Illumina is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Illumina is bearish.
The RSI indicator is at 35.92 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Illumina
New China rule prompts BGI to suspend trisomy testing, GenomeWeb says
Fri, 14 Mar 2014 15:58:40 GMT
Today's Dead Cat Bounce Stock: Illumina (ILMN)
Fri, 14 Mar 2014 14:33:00 GMT
3 Stocks Underperforming Today In The Drugs Industry
Mon, 10 Mar 2014 17:04:00 GMT
WuXi PharmaTech Purchases an Illumina HiSeq X Ten Sequencing System
Mon, 10 Mar 2014 11:42:26 GMT
noodls – SAN DIEGO & SHANGHAI–(BUSINESS WIRE)–Mar. 10, 2014– Illumina, Inc. (NASDAQ:ILMN) and WuXi PharmaTech (Cayman) Inc. (NYSE:WX), a leading pharmaceutical, biotechnology, and medical device R&D outsourcing …
Also on Market Tamer…
Follow Us on Facebook